These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 15252821

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype.
    Haffen E, Vandel P, Broly F, Vandel S, Sechter D, Bizouard P, Bechtel PR.
    Pharmacopsychiatry; 1999 Nov; 32(6):232-4. PubMed ID: 10599932
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline.
    Roberts RL, Mulder RT, Joyce PR, Luty SE, Kennedy MA.
    Hum Psychopharmacol; 2004 Jan; 19(1):17-23. PubMed ID: 14716707
    [Abstract] [Full Text] [Related]

  • 6. [The influence of clomipramine on CYP2D6 activity].
    Szewczuk-Bogusławska M, Kiejna A, Grzesiak M, Beszłej JA, Chlebowska I, Orzechowska-Juzwenko K, Milejski P.
    Psychiatr Pol; 2007 Jan; 41(2):243-9. PubMed ID: 17598433
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antidepressant drugs in the elderly--role of the cytochrome P450 2D6.
    Vandel P.
    World J Biol Psychiatry; 2003 Apr; 4(2):74-80. PubMed ID: 12692778
    [Abstract] [Full Text] [Related]

  • 10. [Retrospective assessment of the antidepressants tolerance in the group of patients with diagnosis of depression and different CYP2D6 genotype].
    Grzesiak M, Beszłej A, Lebioda A, Jonkisz A, Dobosz T, Kiejna A.
    Psychiatr Pol; 2003 Apr; 37(3):433-44. PubMed ID: 13677973
    [Abstract] [Full Text] [Related]

  • 11. Managing rapid metabolizers of antidepressants.
    Kraus RP, Diaz P, McEachran A.
    Depress Anxiety; 2003 Apr; 4(6):320-7. PubMed ID: 9166660
    [Abstract] [Full Text] [Related]

  • 12. [Assessment of CYP2D6 activity as a form of optimizing antidepressant therapy].
    Szewczuk-Bogusławska M, Grzesiak M, Beszłej JA, Kiejna A.
    Psychiatr Pol; 2004 Apr; 38(6):1093-104. PubMed ID: 15779673
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Re: no evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline.
    Gillman PK.
    Hum Psychopharmacol; 2005 Jan; 20(1):61-2; author reply 63-4. PubMed ID: 15614840
    [No Abstract] [Full Text] [Related]

  • 15. [Cytochrome p450 IID6, its role in psychopharmacology].
    Lamard L, Pérault MC, Bouquet S, Guibert S.
    Ann Med Psychol (Paris); 1995 Feb; 153(2):140-3. PubMed ID: 7741408
    [Abstract] [Full Text] [Related]

  • 16. Drug extrapyramidal side-effects or not: is there a dextromethorphan phenotype difference?
    Vandel P, Haffen E, Vandel S, Bonin B, Sechter D, Bizouard P, Dalery J.
    Therapie; 2000 Feb; 55(3):349-53. PubMed ID: 10967711
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Paroxetine-induced conversion of cytochrome P450 2D6 phenotype and occurence of adverse effects.
    Zourková A, Hadasová E.
    Gen Physiol Biophys; 2003 Mar; 22(1):103-13. PubMed ID: 12870705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.